P2‐481: Small molecule BACE‐1 inhibitors are potent, selective and orally active
Michael S. Malamas(Pearl River Community College), Jonathan Bard, Menelas N. Pangalos(AstraZeneca (United Kingdom)), David Riddell(Eli Lilly (United States)), R. L. Magolda, Iwan Gunawan(Pearl River Community College), Erik Wagner(Princeton University), Kristi Fan, Jim Erdei(Pfizer (United States)), Tom Comery(Princeton University), Rajiv Chopra(Texas Instruments (United States)), Peter H. Reinhart(University of Massachusetts Amherst), Steve Jacobsen, Jim Turner(Pfizer (United States)), Albert J. Robichaud(Princeton University), Magid Abou‐Gharbia, Suzan Aschmies(Princeton University), Yun Hu(Princeton University)
Cited by 2
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302
Morphometric analysis of sub-watersheds in Gurdaspur district, Punjab using remote sensing and GIS techniques
|Journal of the Indian Society of Remote Sensing|2005|278